Quantcast

Latest Prostate cancer Stories

2014-03-27 08:33:33

DUBLIN, Mar. 27, 2014 /PRNewswire/ -- Research and Markets ( http://www.researchandmarkets.com/research/djkgl4/therapeutic_class ) has announced the addition of the "Therapeutic Class Overview: Newer Oral Anti Androgens - Expanding Role in the Treatment Paradigm of Prostate Cancer" report to their offering. (Logo: http://photos.prnewswire.com/prnh/20130307/600769) In recent past approval and launch of various newer treatment options like Xtandi (Enzalutamide,...

2014-03-26 23:26:31

A report to the nation’s bladder cancer specialists says more of them should be taking a multidisciplinary approach to treating their patients with bladder cancer. Raleigh, NC (PRWEB) March 26, 2014 Researchers say treating the invasive form of bladder cancer with both surgery and chemotherapy can improve survival, especially if chemotherapy is delivered prior to surgery. Click here to see details of the new report, which has just been posted by Cancer Monthly. In a report presented at...

2014-03-26 16:24:58

DALLAS, March 26, 2014 /PRNewswire-iReach/ -- RnRMarketResearch.com adds "Cancer Test Market & Forecast, Companies Cancer Test Platform, Pipeline Analysis and Clinical Trials - Global" to its store that says Cancer testing has tremendous growth opportunities for the next five years. (Photo: http://photos.prnewswire.com/prnh/20140326/MN91058) Cancer is the second-leading cause of death and disability in the world, behind only heart disease. More people die from cancer every year...

2014-03-26 08:29:17

ARDEN HILLS, Minn., March 26, 2014 /PRNewswire-iReach/ -- Galil Medical, the global leader in interventional oncology cryotherapy treatments, announced the launch of its latest prospective clinical research study, SOLSTICE (Study of Metastatic Lung Tumors Targeted by Interventional Cryoablation Evaluation). Photo - http://photos.prnewswire.com/prnh/20140326/MN90636 The SOLSTICE Clinical Study is the largest multi-center prospective trial focused on the...

2014-03-24 23:00:59

Understanding bone health is critical for advanced stage prostate cancer patients. Malecare Cancer Support is presenting a free teleconference for prostate cancer patients and their families with noted urologist Neil Shore, MD. New York, NY (PRWEB) March 24, 2014 Malecare Prostate Cancer Support will present a teleconference titled, "Bone Health and Prostate Cancer.” The conference is scheduled for Tuesday, March 25, 2014 at 6PM ET. The teleconference is available without cost and...

2014-03-24 16:24:53

TOKYO, March 24, 2014 /PRNewswire/ -- Astellas Pharma Inc. (TSE: 4503) today announced that Astellas has obtained marketing approval of their oral androgen receptor signaling inhibitor, XTANDI(®) capsules 40mg (development code: MDV3100; generic name: enzalutamide) for the treatment of patients with castration-resistant prostate cancer in Japan. Astellas filed the application for approval in Japan in May 2013. XTANDI is a once-daily, oral androgen receptor signaling inhibitor that acts on...

2014-03-24 16:22:35

NORWALK, Conn., March 24, 2014 /PRNewswire/ -- UBM Medica US announces that Cancer Network, the online home of the journal ONCOLOGY presents a special report on the most prevalent cancer for men, prostate cancer. Cancer Network, a leading online community for oncologists and others who treat cancer, offers news, blogs, and podcasts about the latest clinical findings and best practices in oncology. As part of our special series on prostate cancer, we present: -- An interview with...

2014-03-24 12:30:43

Prostate Size, Severe Symptoms Not a Barrier to Success, Say Interventional Radiologists About Nonsurgical Prostate Artery Embolization SAN DIEGO, March 24, 2014 /PRNewswire-USNewswire/ -- Shrinking the prostate without surgery can provide long-term relief to men with this common condition that causes annoying symptoms, such as frequent trips to the bathroom, suggests a study of nearly 500 men. According to research being presented at the Society of Interventional Radiology's 39th...

2014-03-24 08:29:09

NORTH HOLLYWOOD, Calif., March 24, 2014 /PRNewswire/ -- Online health retailer IMS Supplements, Inc. has recently been approved to display a doctor's seal of approval, a major benefit granted by consumer protection service Doctor Trusted. Photo - http://photos.prnewswire.com/prnh/20140324/PH88672 Many consumers have seen television commercials in addition to radio ads for prostate products. When you choose a prostate supplement or any product you put into your body a celebrity...

2014-03-23 23:01:51

An Italian study of 22 clinical trials contains some good news and some bad news for diabetic patients treated with the drug Actos. Raleigh, NC (PRWEB) March 23, 2014 Cancer Monthly is reporting on the results of an Italian Meta-Analysis involving more than 13,197 patients who had taken either the diabetes drug Actos or another thiazolidinedione called rosiglitazone. Researchers at the Careggi Teaching Hospital in Florence, Italy scoured the medical literature for both published and...


Word of the Day
mallemaroking
  • Nautical, the visiting and carousing of sailors in the Greenland ships.
This word is apparently from a confusion of two similar Dutch words: 'mallemerok,' a foolish woman, and 'mallemok,' a name for some persons among the crew of a whaling vessel.